Therapy

Why?

• More arrhythmias are terminated at low doses

SVT: 3 mg adenosine via a central line is more likely to terminate the arrhythmia than via a peripheral line.

Patient	Treatment	Comparison	Outcome	CER	RRR (95% CI)	NNT (95% CI)
SVT a	3 mg adenosine via central vein	3 mg adenosine via peripheral vein	arrhythmia terminated at 10 minutes	37%	110% (26% to 250%)	3 (2 to 6)